Effects of citalopram on blood pressure control in depressive patients with hypertension: A randomized clinical trial

Hossein Namdar1, Elnaz Khani2, Sajad Khiali2

  • 1Cardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Insights

Citalopram, an antidepressant, significantly lowered blood pressure in patients with both hypertension and depression. This study suggests citalopram may be a beneficial addition to standard hypertension treatment.

Area of Science:

  • Cardiovascular Medicine
  • Psychiatry
  • Pharmacology

Background:

  • Hypertension and depression share a bidirectional relationship.
  • Managing both conditions concurrently presents unique challenges.

Purpose of the Study:

  • To investigate the efficacy of citalopram in managing hypertension in patients with comorbid depression.
  • To assess the impact of citalopram on blood pressure levels in this patient population.

Main Methods:

  • A randomized clinical trial involving 72 patients with hypertension and depression.
  • Intervention group received citalopram (20 mg/day) plus standard antihypertensive treatment.
  • Control group received standard antihypertensive treatment alone.

Main Results:

  • After two months, the intervention group showed significant reductions in both systolic and diastolic blood pressure compared to the control group.
  • Diastolic blood pressure was significantly lower in the citalopram group after one month.
  • No significant baseline differences in blood pressure were observed between groups.

Conclusions:

  • Citalopram demonstrated beneficial effects in lowering blood pressure in patients with co-occurring depression and hypertension.
  • This suggests a potential role for citalopram as an adjunct therapy for hypertension in depressed patients.
Abstract

Related Concept Videos

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
380
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
227
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
466
Disorders of the Autonomic Nervous System01:18

Disorders of the Autonomic Nervous System

The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's...
632
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
441
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K